SLC5A2 and heart failure: There has been consistent data to support increased ketogenesis with multiple of the SGLT2-i’s; however, whether this increased ketosis is partially responsible for the reverse remodeling and mortality benefit seen with SGLT-2i use in patients with heart failure is yet to be elucidated [44–47].